On December, 16 Akrikhin took part in the preconference day of the I Annual Conference of the Eurasian Affiliate of the International Society for Pharmaceutical Engineering (ISPE), where top experts and regulators of the Eurasian market held a discussion on some specific aspects of pharmaceutical engineering and regulatory trends in the context of instability.

The online preconference of the Eurasian Affiliate of the ISPE covered a most extensive list of subjects in pharmaceutical engineering and design, and related processes. The opening was attended by ISPE CEO & President Hartman, ISPE Vice President Thomas Zimmer, CEO of State Institute of Drugs and Good Practices Vladislav Shestakov, and representatives of Russian drug manufacturers.

Akrikhin became a partner of the conference session titled “An Overview of the New ISPE Guidance Documents in 2019-2020 and Their Use in Practice”, where representatives of the Society, pharmaceutical manufacturers and engineering companies spoke on the highlights of the new ISPE guidance documents in a number of cases. Akrikhin was represented by expert Helen Zabotina, Head of Operational Quality Assurance for Semi-Solids, who offered a case on cross-contamination risk analysis using the ISPE Risk-MaPP standard. Her report was based on the experience in the practical application of the principles of Baseline Guide Vol 7: Risk-Based Manufacture of Pharma Products 2nd Edition in the analysis of risks in drug manufacturing.

We use cookies to improve your experience on our site and to show you personalised advertising. By pressing “I AGREE” you accept our cookies policy.
To find out more, go to cookies policy.